Both in Pharmaceuticals
Cogent Biosciences vs Erasca
Over the past year COGT returned +122.9% and ERAS returned +545.5%; their daily moves had a correlation of 0.14.
COGT +122.9% ERAS +545.5%Growth of $1, one year, split-adjusted
| Metric | COGT | ERAS |
|---|---|---|
| Price | $31.49 | $14.91 |
| Market cap | $5.46B | $5.21B |
| Today | +1.38% | +1.84% |
| 1 month | +3.7% | +4.3% |
| 6 months | −12.2% | +36.8% |
| Year to date | −11.3% | +300.8% |
| 1 year | +103.2% | +526.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $568.8M | $268.7M |
| Dividend yield | — | — |
| Volatility (60d) | 39.1% | 59.7% |
| Short % of float | 13.2% | 14.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).